Not to be a downer on your excitement but you're all getting ahead of yourselves. All these massive revenue calculations for hepafat scan are ridiculous. New technologies do not get used that quickly in medecine. Uptake is slow, and it takes literally YEARS for clinicians to figure out how to use the tech to help patients. Most haven't even heard of it. Clinical trial revenue is faster but lumpy.
Am thinking that RHT can get revenue of about $20 million through a combination of trials and patients ferri and hepa, within 3 years. Then it's not unreasonable to suggest profit will be $2 - $6 million depending on their margins. If that happens by they time profit is $4 million it is v. possible market will pay PE 20 or so. Suddenly we have mcap of $80 million. Thats 200% - 300% gain in share price.
If we get even close to this you can hope for gains of 100% plus within a fairly short period. That is good enough for me.
Not to be a downer on your excitement but you're all getting...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.57M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 116743 | 2 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable